Currently the price is 6,10$, In this post we are going to talk about the listed company Ocular Therapeutix Inc, its leaders are Antony Mattessich (President, Chief Executive Officer & Director), Donald Notman (Chief Financial Officer), Michael H. Goldstein (Chief Medical Officer & Ophthalmology President), Peter Jarrett (Chief Scientific Officer), Rabia Gurses Ozden (Senior Vice President-Clinical Development), they lead it to work in Biotechnology: Pharmaceutical Preparations especially in the North America region.
Today this action begins with yesterday's closing price, desconocido$.
The current range on the same day is from 5,97$ - 6,31$, with a percentage difference of 6,14$ quite wide that helps to be able to do day trading.
The company has an annual revenue of desconocido.
The last value we have registered for the opening is desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].
Buscar
